Moreover, TIRR amplification in human cancer cell lines13 abolishes the recruitment of 53BP1 and its downstream effector RIF1 to DSB sites, thus disrupting 53BP1-dependent DSB repair13. This evidence concerns the gene NUDT16L1 and cancer.